Replies to post #30783 on Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

$20 to $25 end game ($30 if we are fortunate), then ADXS is no longer a standalone entity and is in the hands of a larger, more capable entity, which is in the best interests of patients, and investors will have finally made a profit. We are close to getting a product to market, no need to risk another CEO who fumbles or is misaligned with the company's investors. GLTA